We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Likely to Start New Global COVID-19 Vaccine Trial to Verify Effectiveness
AstraZeneca Likely to Start New Global COVID-19 Vaccine Trial to Verify Effectiveness
AstraZeneca’s COVID-19 vaccine candidate is facing another potential delay as the company plans to undertake a new global clinical trial to confirm the vaccine’s 90 percent efficacy based on a one-and-a-half-dose regimen.